The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...
A new technique may reprogram immune cells inside the body, offering faster, simpler, and more accessible cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results